First-, second-, third-line therapy for metastatic renal cell carcinoma (mRCC): Benchmarks for trials design from the International mRCC Database Consortium (IMDC) Heng, D., Rini, B. I., Lee, J., Kroeger, N., Srinivas, S., Harshman, L., Knox, J. J., Bjarnason, G. A., MacKenzie, M. J., Wood, L., Vaishampayan, U. N., Agarwal, N., Pal, S., Tan, M., Rha, S., Yuasa, T., Donskov, F., Bamias, A., North, S. A., Choueiri, T. K. AMER SOC CLINICAL ONCOLOGY. 2013

View details for Web of Science ID 000335419601600